CSPCY (CSPC Pharmaceutical Group) Cyclically Adjusted PB Ratio: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSPCY CSPC Pharmaceutical Group Ltd CSPCY
73 GF Score
Price $4.39
GF Value $3.32
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CSPC Pharmaceutical Group  (OTCPK:CSPCY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio Related Terms


CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.85 5.27 4.24 2.46 3.88

CSPC Pharmaceutical Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 0.00 3.88 0.00 0.00

CSPCY vs LLY, JNJ, ABBV: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio falls into.


CSPCY
73GF Score
CSPC Pharmaceutical Group Ltd CSPCY
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CSPC Pharmaceutical Group's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, CSPC Pharmaceutical Group's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/116.3033*116.3033
=0.000

Current CPI (Mar. 2026) = 116.3033.

CSPC Pharmaceutical Group Quarterly Data

Book Value per Share CPI Adj_Book
201603 0.000 102.200 0.000
201606 0.410 101.400 0.470
201609 0.000 102.400 0.000
201612 0.450 102.600 0.510
201703 0.000 103.200 0.000
201706 0.486 103.100 0.548
201709 0.000 104.100 0.000
201712 0.647 104.500 0.720
201803 0.000 105.300 0.000
201806 0.702 104.900 0.778
201809 0.000 106.600 0.000
201812 0.730 106.500 0.797
201903 0.000 107.700 0.000
201906 0.798 107.700 0.862
201909 0.000 109.800 0.000
201912 0.879 111.200 0.919
202003 0.000 112.300 0.000
202006 0.942 110.400 0.992
202009 0.000 111.700 0.000
202012 1.141 111.500 1.190
202103 0.000 112.662 0.000
202106 1.274 111.769 1.326
202109 0.000 112.215 0.000
202112 1.366 113.108 1.405
202203 0.000 114.335 0.000
202206 1.404 114.558 1.425
202212 1.452 115.116 1.467
202303 0.000 115.116 0.000
202306 1.500 114.558 1.523
202309 0.000 115.339 0.000
202312 1.569 114.781 1.590
202403 0.000 115.227 0.000
202406 1.634 114.781 1.656
202409 0.000 115.785 0.000
202412 1.544 114.893 1.563
202503 0.000 115.116 0.000
202506 1.622 114.907 1.642
202509 0.000 115.471 0.000
202512 1.652 115.832 1.659
202603 0.000 116.303 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of $4.39 is trading 32.2% above its estimated GF Value™ of $3.32. GuruFocus considers CSPC Pharmaceutical Group to be Significantly Overvalued.

Key valuation signals for CSPCY:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $3.32 vs. price of $4.39 (32.2% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
73GF Score

Get the complete analysis for CSPCY

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.39
Price
$3.32
GF Value